Volume: 45 Issue: 1
Biological activity spectra of the main phytochemicals of Silybum marianum L. Gaertn. by in silico study
Year: 2023, Page: 38-45, Doi: https://doi.org/10.62029/jmaps.v45i1.ranjini
Received: March 17, 2023 Accepted: May 1, 2023 Published: Oct. 27, 2023
The main objective of bioinformatics is to augment the perception of biological data. Bioinformatics gains information from computer analysis of biological practices. Biologically active principles have both pharmaceutical and adverse effects on the organisms. PASS (Prediction of Activity Spectra for Substances) software is used to estimate the general efficacy and safety of the phytochemicals. PASS simultaneously predicts several hundreds of biological activities of natural and synthetic chemical compounds. The average precision of prediction is about 90%. The extract from the seed of Silybum marianum contains silymarin, which is a complex mixture of polyphenolic molecules, including seven closely related flavonolignans, namely, silybin A, silybin B, isosilybin A, isosilybin B, silychristin, isosilychristin, silydianin and one flavonoid namely taxifolin. Silymarin has been used to treat various hepatic diseases, including chronic and acute liver diseases in canines and felines. It is used as a nutritional supplement to treat liver diseases and toxicities and prevent certain cancers in companion animals. In the present study, the main phytochemicals reported from Silybum marianum L. Gaertn. were subjected to in-silico evaluation using PASS software. The methods, biological activity spectra and significance of the in-silico study are discussed.
Keywords: Efficacy, In Silico, PASS, Phytochemicals, Silybum marianum, Toxicity
Karkanis, A., Bilalis, D., & Efthimiadou, A. (2011). Cultivation of milk thistle (Silybum marianum L. Gaertn.), a medicinal weed. Industrial Crops and Products, 34(1), 825–830.
Anzali, S., Barnickel, G., Cezanne, B., Krug, M., & Poroikov, V. V. (2001). Discriminating between drugs and non-drugs by prediction of activity spectra for substances. Journal of Medicinal Chemistry, 44, 432–437.
Evans, W. C. (2005). Pharmacognosy. Elsevier.
Hogan, F. S., Krishnegowda, N. K., Mikhailova, M., & Kahlenberg, M. S. (2007). Flavonoid silibinin inhibits proliferation and promotes cell-cycle arrest of human colon cancer cells. Journal of Surgical Research, 143, 58–65.
Gazák, R., Walterová, D., & Křen, V. (2007). Silybin and silymarin—New and emerging applications in medicine. Current Medicinal Chemistry, 14, 315–338.
Karimi, G., Vahabzadeh, M., Lari, P., Rashedinia, M., & Moshiri, M. (2011). Silymarin, a promising pharmacological agent for treatment of diseases. Iranian Journal of Basic Medical Sciences, 14, 308–317.
Kroll, D. J., Shaw, H. S., & Oberlies, N. H. (2007). Milk thistle nomenclature: Why it matters in cancer research and pharmacokinetic studies? Integrative Cancer Therapies, 6, 110–119.
Lagunin, A. A., Gomazkov, O. A., Filimonov, D. A., Gureeva, T. A., Dilakyan, E. A., Kungaevskaya, E. V., & Solovyeva, N. I. (2003). Computer-aided selection of potential antihypertensive compounds with dual mechanisms of action. Journal of Medicinal Chemistry, 46, 326–332
Parasuraman, S. (2011). Prediction of activity spectra of substances. Journal of Pharmacology and Pharmacotherapeutics, 2, 252–253.
Poroikov, V. V., & Filimonov, D. A. (2002). How to acquire new biological activities in old compounds by computer prediction? Journal of Computer-Aided Molecular Design, 16, 819–824.
Ramakrishnan, G., Elinos-Baez, C. M., Jagan, S., Augustine, T. A., & Kamaraj, S. (2009). Silymarin inhibited proliferation and induced apoptosis in hepatic cancer cells. Cell Proliferation, 42, 229–240.
Sadym, A., Lagunin, A., Poroikov, V. V., & Filimonov, D. A. (2003). Prediction of biological activity spectra via Internet. SAR and QSAR in Environmental Research, 14, 339–347.
Vepriková, Z., Zachariášová, M., Dzuman, Z., Zachariášová, A., Fenčlová, M., Slavíková, P., Václavíková, M., Maštovská, K., Hengst, D., & Hajšlová, J. (2015). Mycotoxins in plant-based dietary supplements: Hidden health risk for consumers. Journal of Agricultural and Food Chemistry, 63, 633–643.
Wenwu, J., Lin, L., & Tsai, T. (2009). Drug–drug interactions of silymarin from the perspective of pharmacokinetics. Journal of Ethnopharmacology, 121, 185–193.
© CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow-226015
Ranjini, R. (2023). Biological activity spectra of the main phytochemicals of Silybum marianum L. Gaertn. by in silico study. Journal of Medicinal and Aromatic Plant Sciences, 45(1), 38–45.
